|
|
OM is a challenging disorder for the clinician and scientist, with both learning from the other for the betterment of the patient. The future required answers to why the ocular muscles are so frequently involved by MG, whether the generalization of the disease may be limited by early corticosteroid treatment, and what treatment options may be developed which will improve symptoms without long-term complications. |
|